Dissertation > Excellent graduate degree dissertation topics show

Evaluation of clinical pathway management of patients with lung cancer surgery

Author: MaXinMei
Tutor: HeJia
School: Third Military Medical University
Course: Social Medicine and Health Management
Keywords: Patients with lung cancer surgery Clinical pathways Evaluation of
CLC: R734.2
Type: Master's thesis
Year: 2011
Downloads: 55
Quote: 0
Read: Download Dissertation

Abstract

Objective: To survey comparing the First People's Hospital of Yunnan Province, Thoracic Surgery, 2002-2009 treated lung cancer surgery, hospitalization information and differences in the cost of hospitalization, the evaluation of the First People's Hospital of Yunnan Province thoracic surgery for lung cancer patients undergoing clinical path the effect of management, to provide a basis for the department in charge of the rational allocation of health resources in the treatment of lung cancer, and to develop appropriate measures to control medical costs of lung cancer, to curb excessive medical or irrational consumption, conserve limited medical resources, and better serve the masses of the people, and ultimately reduce the burden of lung cancer patients and families. Methods: by consulting Yunnan First People's Hospital of Thoracic Surgery experts, clinical treatment options for lung cancer surgery patients in 2002 to 2009, no significant changes in the condition of patients admitted during no significant difference in the premise, a retrospective survey research methods, in accordance with the \HIS medical record management module, according to hospital number one by one query out patient surgery coding, total cost of hospitalization, the breakdown of costs and other information, delete inpatient total cost of less than $ 10,000 lung cancer surgery patient information obtained in 2002 to September 2009 during thoracic surgery research data of 489 cases of lung cancer surgery patients, the establishment of a database. Study Group clinical pathway management of 293 cases of lung cancer surgery, thoracic surgery patients; unused clinical path to management of 196 cases of lung cancer surgery, thoracic surgery patients as a control group, descriptive statistical analysis of data with SPSSl6.0 statistical analysis software, significant test, analysis of variance, correlation analysis. Results: the treatment of lung cancer surgery, the patient's clinical programs in 2002-2009 no significant changes, there is no significant difference in the conditions of patients were treated, the gender composition of the two groups of patients, age, Payment by statistical tests, no significant The differences between the two groups of patients were comparable. After on comparative analysis, study group hospitalized total days the number was significantly less than the control group (t = 11.768, P lt; 0.01); preoperative hospitalization days the number of significant significantly less than the control group before and after lung cancer surgery patient clinical path management ((t = 4.391, P lt; 0.01); average inpatient total number of days and preoperative hospital days and inpatient Year strong correlation between the more recent years, the average length of stay total number of days and preoperative hospitalization days more short. total hospital costs significantly lower than the control group ( t = 2.292, P lt; 0.05), a number of sub-costs (such as western medicine fee, bed fee, examination fee, examination fee, oxygen, etc.) lower than that of the control group (P lt; 0.01 or P lt; 0.05); excluded The average total cost of hospitalization medical expenses price influencing factors reduce the more than the control group, the test (t = 3.724, P lt; 0.01), a number of sub-costs are still lower than those in the control group (P lt; 0.01 or P lt; 0.05) were statistically significant. patient was discharged the outcome of the situation no significant difference test; cure rate significantly improved compared with the original inspection (ⅹ to 2 = 4.123, P lt; 0.05); patient complications significantly reduced compared to the original inspection (ⅹ to 2 = 4.938, P lt; 0.05), with a statistically significant conclusion: no significant change in the clinical treatment of lung cancer surgery patients, the disease did not differ significantly, the gender of patients constitute, age, pay way without significantly with the premise of differences in the clinical pathway management of lung cancer surgery patients shorten hospitalization total days the number of preoperative hospitalization days number, to reduce a patient's hospital stay costs, improve the cure rate of patients with reduce patient complications, full clinical path management control lung cancer surgery patients, duration of hospitalization, medical costs have a certain significance. authorities to develop lung cancer clinical path management to provide a reference for the rational allocation of health resources in the treatment of lung cancer basis will curb excessive medical or irrational consumption, saving limited medical resources, better service to the masses, and ultimately reduce the burden of lung cancer patients and families have a certain sense.

Evaluation of clinical pathway management of patients with lung cancer surgery

Abstract

Related Dissertations